Systematic assessment of patients with severe asthma – when to use a biologic treatment?

Kontakt :  | 2936 3202

Dr Andrew Menzies-Gow is dedicated to provide first class diagnostic and treatment services for the severe asthmatic patients at Royal Brompton Hospital, London, and will share his experience and thoughts on how to achieve improvements in the clinical setting. He will also share insights from published research in the field of mechanisms in severe asthma and potential of approved novel therapies in inflammation. Prof Christer Janson, Uppsala University and member of Nordic Severe Asthma Network, will cover the above topics from a Nordic perspective.
When: Wednesday, November 29th, 2017 at 16.15 – 19.30
Where: Scandic Copenhagen, Vester Søgade 6, København V.
Program:
16.15 Registration and Coffee
16.40 Product News from AstraZeneca Denmark
17.00 Welcome and introduction
Jenny Engström, Nordic Brand Manager, AstraZeneca
17.05 PRECISION - a global program to improve care for patients with severe asthma Karin Heeroma, Nordic Senior Medical Advisor, AstraZeneca
17.15 Systematic assessment of patients with severe asthma – when to use a biologic treatment?
Dr. Andrew Menzies Gow, Royal Brompton Hospital
18.00 Break and local discussion
18.15 Challenges in severe asthma in the Nordics
Prof. Christer Janson, Uppsala University
18.35 Questions and discussion
18.55 Summary and closing words
Prof. Christer Janson, Uppsala University
19.00 Symposium and webcast end
19.00 Sandwich
The live webcast will be held in English. To take part of the live webcast 29th of November 2017, please contact me by phone/e-mail, the latest by 15. November. My contact details are on the next page.

Sted : Scandic Copenhagen, Vester Søgade 6, København V

Invitation: NRSN Q4 2017 Invitation DK HUBS 29112017 - Alle.pdf